Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Abdominal	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
ERCP	O
with	O
sphincterotomy	O
and	O
biliary	O
stent	O
placement	O
on	O
___	O
History	O
of	O
Present	O
Illness:	O
Mrs.	O
___	O
is	O
a	O
very	O
nice	O
___	O
year-old	O
woman	O
with	O
a	O
history	O
of	O
cholecystectomy	O
and	O
ampullar	O
stenosis	O
who	O
presents	O
with	O
RUQ	O
abdominal	O
pain.	O
She	O
states	O
her	O
pain	O
started	O
2	O
days	O
prior	O
to	O
admission,	O
was	O
constant	O
and	O
radiated	O
towards	O
the	O
back.	O
She	O
had	O
nausea,	O
vomit,	O
malaise.	O
Denies	O
fever,	O
chills,	O
changes	O
in	O
her	O
bowel	O
movements,	O
hematochezia	B-Lower_gastrointestinal_haemorrhage
or	O
melena.	B-Upper_gastrointestinal_haemorrhage
Unable	O
able	O
to	O
tolerate	O
oral	O
intake.	O
Presenting	O
vitals	O
were	O
T	O
101.5,	O
HR	O
68,	O
BP	O
152/76,	O
RR	O
16,	O
SpO2	O
95%	O
RA.	O
In	O
ED,	O
Unasyn	O
3gm	O
given	O
and	O
a	O
right	O
IJ	O
central	O
line	O
was	O
placed.	O
She	O
underwent	O
ERCP	O
that	O
showed	O
1-cm	O
stone	O
in	O
the	O
common	O
bile	O
duct.	O
Patient	O
became	O
hypoxic	O
from	O
the	O
conscious	O
sedation,	O
so	O
the	O
stone	O
was	O
not	O
removed	O
to	O
expedite	O
the	O
procedure.	O
A	O
plastic	O
biliary	O
stent	O
was	O
successfully	O
placed.	O
Post-ERCP,	O
she	O
was	O
admitted	O
to	O
the	O
ICU	O
with	O
a	O
diagnosis	O
of	O
cholangitis.	O
ICU	O
course:	O
In	O
the	O
ICU,	O
the	O
patient	O
was	O
continued	O
on	O
Zosyn,	O
her	O
RUQ	O
pain	O
significantly	O
improved,	O
and	O
she	O
began	O
to	O
tolerate	O
fluids.	O
On	O
___,	O
she	O
developed	O
shortness	O
of	O
breath	O
that	O
improved	O
with	O
administration	O
of	O
furosemide.	O
Nebulizer	O
treatments	O
also	O
given.	O
At	O
time	O
of	O
transfer	O
to	O
floor,	O
O2	O
sat	O
was	O
95%	O
on	O
2L	O
nasal	O
canula.	O
Lisinopril	O
restarted,	O
but	O
Atenolol	O
and	O
Nifedipine	O
held	O
for	O
concern	O
of	O
lower	O
heart	O
rate.	O
She	O
was	O
transferred	O
to	O
the	O
floor	O
and	O
felt	O
improvement	O
in	O
her	O
abdominal	O
pain.	O
Denied	O
shortness	O
of	O
breath,	O
chest	O
pain.	O
Past	O
Medical	O
History:	O
1.	O
Hypertension	O
2.	O
Ampullary	O
stenosis	O
3.	O
Status	O
post	O
cholecystectomy	O
for	O
gallstones	O
4.	O
History	O
of	O
sphincterotomy	O
(as	O
described	O
above)	O
5.	O
Osteoporosis	O
6.	O
Gastroesophageal	O
reflux	O
disease	O
7.	O
External	O
hemorrhoids	O
8.	O
Cerebrovascular	O
accident	O
in	O
___	O
(right	O
pontine)	O
9.	O
___	O
diseae	O
10.	O
Chronic	O
low	O
back	O
pain	O
with	O
sciatica	O
11.	O
Urinary	O
frequency	O
and	O
urge	O
incontinence	O
12.	O
Diverticulosis	O
13.	O
Chronic	O
pancreatitis	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
of	O
MI,	O
stroke,	O
son	O
prostate	O
cancer.	O
Daughter	O
with	O
___.	O
Physical	O
Exam:	O
Admission	O
Exam:	O
VS:	O
Temp	O
97.8	O
F,	O
BP	O
108/30	O
mmHg,	O
HR	O
78	O
BPM,	O
RR	O
14	O
,	O
O2-sat	O
93%	O
RA	O
GEN:	O
Well-appearing	O
woman	O
in	O
NAD,	O
comfortable,	O
jaundiced	O
(skin,	O
mouth,	O
conjuntiva)	O
HEENT:	O
NC/AT,	O
PERRLA,	O
EOMI,	O
sclerae	O
icteric,	O
MMM,	O
OP	O
clear	O
NECK:	O
Supple,	O
no	O
thyromegaly,	O
no	O
JVD,	O
no	O
carotid	O
bruits	O
LUNGS:	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
HEART:	O
PMI	O
non-displaced,	O
RRR,	O
no	O
MRG,	O
nl	O
S1-S2	O
ABDOMEN:	O
NABS,	O
soft/NT/ND,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding.	O
EXTREMITIES:	O
WWP,	O
no	O
c/c/e,	O
2+	O
peripheral	O
pulses	O
(radials,	O
DPs)	O
SKIN:	O
No	O
rashes	O
or	O
lesions	O
LYMPH:	O
No	O
cervical,	O
axillary,	O
or	O
inguinal	O
LAD	O
NEURO:	O
Awake,	O
A&Ox3,	O
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout,	O
DTRs	O
2+	O
and	O
symmetric,	O
cerebellar	O
exam	O
intact,	O
steady	O
gait	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Exam	O
on	O
transfer	O
to	O
floor	O
on	O
___:	O
VS:	O
98.9,	O
154/56,	O
80,	O
18,	O
97%	O
on	O
2L	O
GEN:	O
NAD	O
HEENT:	O
EOMI,	O
MMM,	O
anicteric	O
sclerae,	O
no	O
oral	O
lesions	O
NECK:	O
Supple,	O
R	O
IJ	O
s/p	O
removal	O
with	O
bandage	O
CHEST:	O
CTAB	O
CV:	O
RRR,	O
normal	O
s1	O
and	O
s2,	O
no	O
murmurs	O
ABD:	O
Soft,	O
nondistended,	O
bowel	O
sounds	O
present,	O
mild	O
tenderness	O
in	O
right	O
upper/lower	O
quadrants	O
and	O
midepigastrum,	O
no	O
rebound	O
tenderness,	O
no	O
guarding	O
EXT:	O
No	O
lower	O
extremity	O
edema	O
SKIN:	O
No	O
rash	O
NEURO:	O
Awake,	O
alert,	O
oriented	B-Delirium
x3,	O
CN	O
___	O
intact,	O
strength	O
___	O
BUE/BLE,	O
sensory	O
intact	O
throughout,	O
fluent	O
speech	O
PSYCH:	O
Calm,	O
appropriate	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
WBC-13.8*#	O
RBC-4.09*	O
Hgb-12.9	O
Hct-39.2	O
MCV-96	O
Plt	O
___	O
Neuts-77*	O
Bands-14*	O
Lymphs-6*	O
Monos-3	O
Eos-0	O
Baso-0	O
___	O
Glucose-216*	O
UreaN-23*	O
Creat-1.1	O
Na-138	O
K-5.8*	O
Cl-98	O
HCO3-26	O
AnGap-20	O
ALT-723*	O
AST-979*	O
LD(LDH)-1269*	O
CK(CPK)-99	O
AlkPhos-120*	O
TotBili-3.5*	O
Lipase-44	O
HBsAg-NEGATIVE	O
HBsAb-POSITIVE	O
HBcAb-NEGATIVE	O
HAV	O
Ab-POSITIVE	O
Labs	O
on	O
transfer	O
from	O
ICU	O
to	O
floor	O
___:	O
WBC-8.6	O
RBC-3.12*	O
Hgb-10.0*	O
Hct-30.2*	O
MCV-97	O
Plt	O
Ct-83*	O
Glucose-193*	O
UreaN-18	O
Creat-1.0	O
Na-138	O
K-3.0*	O
Cl-103	O
HCO3-25	O
AnGap-13	O
ALT-51*	O
AST-120*	O
LD(LDH)-170	O
AlkPhos-65	O
Amylase-44	O
TotBili-1.5	O
Lipase-14	O
Calcium-8.0*	O
Phos-2.2*	O
Mg-1.6	O
Lactate-1.6	O
MICRO:	O
Blood	O
Culture	O
___:	O
+Ecoli	O
and	O
Enterococcus,	O
susceptible	O
to	O
ampicillin	O
Urine	O
Culture	O
___:	O
No	O
growth	O
Blood	O
cultures	O
___	O
x	O
2:	O
Gram	O
negative	O
rods	O
Blood	O
Culture	O
___:	O
No	O
growth	O
to	O
date	O
Stool	O
C-diff:	O
Pending	O
collection	O
Imaging:	O
CT	O
Abdomen	O
and	O
Pelvis	O
___:	O
1.	O
Stable	O
pneumobilia	O
and	O
proximal	O
biliary	O
dilatation.	O
2.	O
Left	O
adnexal	O
lesion,	O
2.6	O
cm.	O
Recommend	O
ultrasound	O
for	O
further	O
characterization,	O
and	O
to	O
exclude	O
a	O
solid	O
lesion/cyst	O
with	O
mural	O
nodule	O
in	O
this	O
postmenopausal	O
woman.	O
ERCP	O
___:	O
Findings:	O
Esophagus:	O
Limited	O
exam	O
of	O
the	O
esophagus	O
was	O
normal	O
Stomach:	O
Limited	O
exam	O
of	O
the	O
stomach	O
was	O
normal	O
Duodenum:	O
Limited	O
exam	O
of	O
the	O
duodenum	O
was	O
normal	O
Major	O
Papilla:	O
Evidence	O
of	O
a	O
previous	O
wide	O
open	O
sphincterotomy	O
was	O
noted	O
in	O
the	O
major	O
papilla.	O
Pus	O
was	O
noted	O
at	O
the	O
ampulla.	O
Cannulation:	O
Cannulation	O
of	O
the	O
biliary	O
duct	O
was	O
successful	O
and	O
deep	O
using	O
a	O
free-hand	O
technique.	O
Contrast	O
medium	O
was	O
injected	O
resulting	O
in	O
complete	O
opacification.	O
Biliary	O
Tree:	O
A	O
single	O
15	O
mm	O
stone	O
that	O
was	O
causing	O
partial	O
obstruction	O
was	O
seen	O
at	O
the	O
lower	O
third	O
of	O
the	O
common	O
bile	O
duct.	O
The	O
bile	O
duct	O
was	O
dilated	O
to	O
15	O
mm.	O
The	O
rest	O
of	O
the	O
biliary	O
tree	O
was	O
normal.	O
Detailed	O
cholangiogram	O
was	O
not	O
obtained	O
due	O
to	O
suspicion	O
of	O
cholangitis.	O
Procedures:	O
A	O
5cm	O
by	O
___	O
Double	O
pig-tail	O
biliary	O
stent	O
was	O
placed	O
successfully.	O
Impression:	O
S/P	O
sphincterotomy	O
-	O
this	O
was	O
widely	O
patent.	O
Pus	O
noted	O
at	O
the	O
ampulla.	O
Stone	O
at	O
the	O
lower	O
third	O
of	O
the	O
common	O
bile	O
duct,	O
dilation	O
of	O
bile	O
duct	O
to	O
15	O
mm,	O
other	O
normal	O
biliary	O
tree.	O
A	O
double	O
pig-tail	O
stent	O
was	O
placed	O
in	O
the	O
bile	O
duct.	O
Otherwise	O
normal	O
ercp	O
to	O
third	O
part	O
of	O
the	O
duodenum	O
TTE	O
___	O
The	O
left	O
atrium	O
is	O
mildly	O
dilated.	O
The	O
right	O
atrial	O
pressure	O
is	O
indeterminate.	O
Left	O
ventricular	O
wall	O
thickness,	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
are	O
normal	O
(LVEF	O
>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
masses	O
or	O
vegetations	O
are	O
seen	O
on	O
the	O
aortic	O
valve.	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
No	O
mass	O
or	O
vegetation	O
is	O
seen	O
on	O
the	O
mitral	O
valve.	O
Moderate	O
(2+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
a	O
restrictive	O
filling	O
abnormality,	O
with	O
elevated	O
left	O
atrial	O
pressure.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Significant	O
pulmonic	O
regurgitation	O
is	O
seen.	O
The	O
end-diastolic	O
pulmonic	O
regurgitation	O
velocity	O
is	O
increased	O
suggesting	O
pulmonary	O
artery	O
diastolic	O
hypertension.	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
Discharge	O
labs:	O
___	O
06:37AM	O
BLOOD	O
WBC-6.8	O
RBC-3.29*	O
Hgb-10.4*	O
Hct-31.5*	O
MCV-96	O
MCH-31.5	O
MCHC-32.8	O
RDW-13.8	O
Plt	O
___	O
___	O
06:37AM	O
BLOOD	O
Glucose-100	O
UreaN-14	O
Creat-0.9	O
Na-141	O
K-3.7	O
Cl-104	O
HCO3-30	O
AnGap-11	O
___	O
06:37AM	O
BLOOD	O
Calcium-8.5	O
Phos-3.0	O
Mg-1.___	O
year-old	O
woman	O
presents	O
with	O
cholangitis	O
___	O
choledocholithiasis	O
s/p	O
ERCP	O
with	O
biliary	O
stent	O
placement.	O
Gallstone	O
was	O
not	O
removed	O
because	O
of	O
the	O
patient's	O
tenous	O
condition.	O
The	O
plan	O
will	O
be	O
to	O
repeat	O
the	O
ERCP	O
in	O
one	O
month	O
to	O
remove	O
the	O
stone.	O
Patient	O
was	O
also	O
with	O
bacteremia	O
with	O
E.	O
Coli	O
and	O
Enterococcus	O
likely	O
___	O
biliary	O
source.	O
Patient	O
initially	O
on	O
Zosyn,	O
but	O
because	O
of	O
thrombocytopenia	O
was	O
changed	O
over	O
to	O
Vanco	O
and	O
Cipro.	O
This	O
was	O
finally	O
changed	O
to	O
ampicillin	O
when	O
susceptibilities	O
resulted.	O
#	O
Cholangitis:	O
RUQ	O
pain,	O
fever,	O
leukocytosis	O
with	O
bandemia,	O
AST	O
979,	O
ALT	O
723,	O
AP	O
120,	O
TB	O
3.5	O
and	O
direct	O
of	O
2.4.	O
ERCP	O
was	O
performed	O
and	O
a	O
double	O
pigtail	O
plastic	O
stent	O
was	O
placed.	O
Her	O
hemodynamics	O
remained	O
stable.	O
Blood	O
cultures	O
were	O
positive	O
for	O
gram	O
negative	O
rods,	O
and	O
she	O
was	O
treated	O
with	O
IV	O
Zosyn.	O
Hepatitis	O
serologies	O
demonstrated	O
previous	O
hepatitis	O
A	O
exposure.	O
She	O
developed	O
bacteremia	O
(see	O
below)	O
and	O
will	O
continue	O
antibiotics	O
until	O
___.	O
She	O
will	O
need	O
ERCP	O
follow	O
up	O
in	O
1	O
month	O
for	O
repeat	O
ERCP	O
and	O
stent	O
placement.	O
#	O
E.	O
Coli	O
and	O
Enterococcus	O
bacteremia	O
both	O
susceptible	O
to	O
Ampicillin.	O
Pt	O
initially	O
on	O
Zosyn,	O
then	O
changed	O
to	O
Vanco	O
and	O
Ciprofloxacin	O
given	O
thrombocytopenia.	O
ID	O
was	O
consulted	O
and	O
did	O
not	O
recommend	O
cardiac	O
imaging	O
given	O
that	O
the	O
likely	O
source	O
was	O
the	O
biliary	O
tree	O
and	O
surveillance	O
cultures	O
were	O
negative.	O
She	O
was	O
converted	O
to	O
ampicillin	O
and	O
should	O
continue	O
a	O
14	O
day	O
course	O
since	O
last	O
negative	O
culture	O
(___).	O
#	O
Shortness	O
of	O
breath	O
likely	O
___	O
fluid	O
overload:	O
Patient	O
was	O
intermittently	O
tachypneic	O
and	O
wheezing	O
and	O
was	O
treated	O
with	O
albuterol	O
nebs	O
and	O
lasix	O
with	O
improvement.	O
ECHO	O
ordered	O
to	O
evaluate	O
for	O
systolic	O
or	O
diastolic	O
dysfunction.	O
She	O
was	O
found	O
to	O
have	O
restrictive	O
filling	O
pressures	O
and	O
elevated	O
___.	O
She	O
will	O
be	O
discharged	O
on	O
lasix	O
10mg	O
daily	O
until	O
she	O
sees	O
her	O
PMD.	O
She	O
will	O
need	O
cardiology	O
follow	O
up	O
given	O
her	O
disease.	O
#	O
Thrombocytopenia:	O
PLTs	O
decreased	O
to	O
83	O
(___)	O
from	O
182	O
on	O
admission.	O
Pt	O
not	O
on	O
heparin,	O
thought	O
to	O
be	O
___	O
sepsis	O
at	O
admission.	O
Hemolysis	O
labs	O
not	O
concerning	O
for	O
DIC,	O
and	O
less	O
likely	O
thought	O
to	O
be	O
due	O
to	O
ITP	O
or	O
TTP.	O
After	O
discontinuation	O
of	O
Zosyn,	O
the	O
platelets	O
increased	O
and	O
remained	O
stable.	O
On	O
discharge,	O
her	O
platelets	O
were	O
252.	O
#	O
Hypertension:	O
Lisinopril	O
restarted	O
in	O
ICU.	O
Atenolol	O
and	O
Nifedipine	O
restarted	O
on	O
the	O
floor.	O
Blood	O
pressures	O
were	O
well	O
controlled	O
on	O
the	O
floor.	O
#	O
GERD:	O
Pantoprazole	O
was	O
started.	O
#	O
___	O
disease:	O
Continued	O
Carbidopa-Levodopa	O
#	O
Diverticulosis:	O
Stable.	O
Guaiac	O
negative	O
stools.	O
#	O
DVT	O
prophylaxis:	O
mechanical	O
#	O
Code	O
status:	O
Full	O
Code	O
Medications	O
on	O
Admission:	O
Atenolol	O
75	O
mg	O
PO	O
Daily	O
Carbidopa-Levodopa	O
___	O
1	O
tab	O
TID	O
Lidocaine	O
5%	O
patch	O
Creon	O
10	O
249	O
mg	O
EC	O
2	O
capsules	O
with	O
meals	O
Lisinopril	O
40	O
mg	O
PO	O
Daily	O
Nifedipine	O
SR	O
60	O
mg	O
PO	O
Daily	O
Omeprazole	O
40	O
mg	O
PO	O
Daily	O
Detrol	O
___	O
2	O
mg	O
PO	O
Daily	O
Tramadol	O
50	O
mg	O
PO	O
BID	O
Zmbien	O
5	O
mg	O
PO	O
QHS	O
Aspirin	O
81	O
mg	O
PO	O
Daily	O
Discharge	O
Medications:	O
1.	O
Carbidopa-Levodopa	O
___	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
2.	O
Lipase-Protease-Amylase	O
12,000-38,000	O
-60,000	O
unit	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
Two	O
(2)	O
Cap	O
PO	O
TID	O
W/MEALS	O
(3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS).	O
3.	O
Tolterodine	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
Atenolol	O
50	O
mg	O
Tablet	O
Sig:	O
1.5	O
Tablets	O
PO	O
DAILY	O
(Daily).	O
5.	O
Lisinopril	O
20	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
Nifedipine	O
60	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
PO	O
DAILY	O
(Daily).	O
7.	O
Pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
Q24H	O
(every	O
24	O
hours).	O
Disp:*30	O
Tablet,	O
Delayed	O
Release	O
(E.C.)(s)*	O
Refills:*0*	O
8.	O
Ampicillin	O
250	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
Q8H	O
(every	O
8	O
hours)	O
for	O
9	O
days.	O
Disp:*27	O
Capsule(s)*	O
Refills:*0*	O
9.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
every	O
other	O
day.	O
Disp:*15	O
Tablet(s)*	O
Refills:*0*	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES:	O
-	O
Cholangitis	O
-	O
Choledocholithiasis	O
-	O
Bacteremia	O
with	O
E.	O
Coli	O
and	O
Enterococcus	O
-	O
Thrombocytopenia,	O
possibly	O
from	O
Zosyn	O
-	O
Hypoxia	O
SECONDARY	O
DIAGNOSES:	O
-	O
Hypertension	O
-	O
Gastroesophageal	O
reflux	O
disease	O
-	O
___	O
disease	O
-	O
Chronic	O
urinary	O
incontinence	O
-	O
Osteoporosis	O
-	O
Diverticulosis	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive	O
Ambulatory	B-Independently_mobile
and	O
independent	B-Independently_mobile
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
with	O
abdominal	O
pain.	O
An	O
ERCP	O
was	O
performed	O
which	O
showed	O
gallstones	O
obstructing	O
your	O
bile	O
ducts.	O
A	O
stent	O
was	O
placed	O
which	O
improved	O
the	O
flow	O
of	O
bile.	O
Blood	O
tests	O
showed	O
a	O
blood	O
infection,	O
and	O
you	O
are	O
being	O
treated	O
with	O
antibiotics.	O
MEDICATION	O
CHANGES:	O
1.	O
START:	O
Ampicillin	O
500mg	O
one	O
tablet	O
three	O
times	O
daily	O
until	O
___	O
to	O
complete	O
14-day	O
course	O
of	O
antibiotics	O
(renally	O
dosed)	O
2.	O
CHANGE:	O
Omeprazole	O
to	O
Pantoprazole	O
40mg	O
one	O
tablet	O
daily	O
(your	O
preference)	O
3.	O
Start	O
lasix	O
10mg	O
daily.	O
4.	O
Do	O
NOT	O
take	O
aspirin	O
for	O
5	O
days	O
after	O
your	O
ERCP.	O
Followup	O
Instructions:	O
___	O

